TABLE 1.
Overview of final study selection.
| First author (year) | Design | Size, n | Age, years | Female, n (%) | Observation duration, months |
| Atsuumi et al. (9) | Case report | 1 | 53.0 | 0 (0.0%) | 24 |
| °Busweiler et al. (10) | Retrospective case-control | 54 | 46.0 ± 2.1 | 35 (64.8%) | 96 |
| Eguchi et al. (11) | Case report | 1 | 66.0 | 0 (0.0%) | 12 |
| Iskos et al. (12) | Retrospective case series | 2 | 28.5 ± 0.5 | 0 (0.0%) | 11 ± 3 |
| °Jardine et al. (6) | Prospective cohort | 69 | 47.0 ± 15.0 | 46 (66.7%) | 180 |
| *Kapoor (13) | Prospective cohort | 9 | |||
| *Khadilkar et al. (14) | Retrospective cohort | 5 | |||
| Marrison and Parry (15) | Case report | 1 | 65.0 | 0 (0.0%) | |
| Overdijk et al. (16) | Case report | 1 | 45.0 | 1 (100%) | |
| Rytlewski et al. (17) | Case report | 1 | 41.0 | 1 (100%) | 60 |
| Shahab et al. (18) | Retrospective case series | 5 | 44.4 ± 13.8 | 2 (40.0%) | |
| Tewfik et al. (19) | Retrospective case-control | 19 | 70 | ||
| Xu et al. (20) | Retrospective case series | 2 | 50.5 ± 24.5 | 1 (50.0%) | 36 ± 24 |
*Subgroup from larger cohort. °Includes data from the same cohort. Only unique data presented in the study by Busweiler et al. was used in analysis of clinical characteristics and symptoms. Continuous variables are presented as mean ± standard deviation if available.